Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer. Implications for response classification. - Schneider,P.M.; Baldus,S.E.; Hölscher,A.H. (Ann Surg, 2005)